Live Breaking News & Updates on Glenmark

Stay informed with the latest breaking news from Glenmark on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Glenmark and stay connected to the pulse of your community

DOJ settles price-fixing charges against generic drug giants

Two major generic drug companies Monday settled charges of criminal price fixing with the Department of Justice (DOJ). The U.S. division of Israel-based Teva will pay a $225 million criminal penalty over five years, and the U.S. division of India-based Glenmark will pay a $30 million criminal penalty, the DOJ announced. The two companies entered…

United-states , Americans , Sanjeev-krishan , Jonathan-kanter , Justice-department-antitrust-division , Department-of-justice , Israel-based-teva , India-based-glenmark , Antitrust-division , Attorney-general-jonathan-kanter , Justice-department , Glenmark

Glenmark gets USFDA nod for generic Tacrolimus ointment

The approval granted by the US Food & Drug Administration (USFDA) is for Tacrolimus ointment, 0.03 per cent, the generic version of Protopic Ointment, 0.03 per cent of Leo Pharma AS, the company said in a statement.

United-states , Glenmark-pharmaceuticals-inc , Glenmark-pharmaceuticals-ltd-on , Us-food-drug-administration , Pharmaceuticals-ltd , Drug-administration , Protopic-ointment , Leo-pharma , Business , Companies , Glenmark

ChrysCapital still in race to buy controlling stake in Glenmark Life Sciences

Private equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bidder Nirma. Along with Nirma and ChrysCapital, Sekhmet Pharmaventures backed by PE firms PAG, CX Partners and Samara Capital also in the list of potential investors in the race to acquire Glenmark Pharma stake in GLS.

Samara , Samarskaya-oblast- , Russia , India , Sekhmet-pharmaventures , Glenmark-pharma , Exchange-board-of-india , Glenmark-life-sciences , Exchange-board , Samara-capital , Chryscapital-still , Buy-controlling-stake

Glenmark Pharma reports revenue growth of 22.5%, EBITDA growth of 46.2% YoY for Q1 FY 2023-24

Pti: Glenmark Pharma reports revenue growth of 22.5%, EBITDA growth of 46.2% YoY for Q1 FY 2023-24

India , Indian-railways , Press-trust-of-india , Glenmark , Pharma , Reports , Revenue , Growth , Of , 22 , 5

Glenmark Pharma and OMRON Healthcare India Team Up to Combat Hypertension Ignorance Among Young Adults in India

Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company...

Japan , India , Japanese , Alok-malik , Glenmark-pharmaceuticals-limited , Glenmark-pharmaceuticals-ltd , Take-charge , Executive-vice-president , India-formulations , Glenmark , Pharma , And

Omron: Glenmark, Omron join hands to create awareness on blood pressure monitoring

Through the campaign called “Take Charge @18” both the companies are aiming to reach out to around 92,000 healthcare professionals and around 10 crore Indians in one year. Glenmark has initiated discussions with 94 cardiologists acrossIndia, leading to a unanimous consensus that 18 is the ideal age to commence blood pressure screening.

India , Japan , Japanese , Tetsuya-yamada , Glenmark-pharmaceuticals-for-the-take , Indian-council-of-medical-research , Alok-malik , India-business-head , Glenmark-pharmaceuticals , Take-charge , Indian-council , Medical-research

trade generics: Top drugmakers bet on trade generics to grow beyond metros

Trade generics are branded medicines that are not promoted to physicians but are directly sold through retailers and distributors. In India, trade generics have a market share of 20% by volume and 5-6% by value, according to data and analytics firm IQVIA. The segment is growing around 14-15% per annum.

Hyderabad , Andhra-pradesh , India , Bharat , Jan-aushadhi , Umang-vohra , Jan-aushadhi-kendras , Sandeep-singh , Cipla , Top-drugmakers-bet , Trade-generics , Grow-beyond-metros

api: Glenmark Life Sciences Q1 Results: Firm posts 25% rise in profit on API strength

The company, spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, said total revenue from operations climbed 18% to 5.87 billion rupees during the quarter, with regulated markets including the U.S., Europe and India contributing 78%.

India , United-states , Japan , Mumbai , Maharashtra , America , Aurobindo-pharma , Glenmark-life-sciences , India-glenmark-life-sciences , Glenmark-pharmaceuticals , Torrent-pharmaceuticals , Latin-america

Washing powder maker Nirma and Sekhmet vie for $731 million Glenmark Life stake: Sources

Nirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-listed company held by Glenmark Pharmaceuticals Ltd which has a portfolio of 139 molecules and supplies its products to customers in India and abroad including Europe and North America. The company has four plants in India.

India , United-states , Mumbai , Maharashtra , Anjan , Jharkhand , Samara , Samarskaya-oblast- , Russia , America , Glenmark-pharma , Cathy-chan

3 insights to kick-start your day: featuring Glenmark's cancer drug

Good news for cancer patients; MCA intensifies shell cos crackdown; and credit cards pip debit cards.

India , Glenmark-pharma , Fintech-apps , Upi , Glenmark , Mca , Rbi , National-payments-corporation-of-india ,